Browsing by Author "Truong, Emily"

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Letter to the Editor: Serum Identification of At-Risk MASH: The Metabolomics-Advanced Steatohepatitis Fibrosis Score (MASEF)
    (2024) Noureddin, Mazen; Truong, Emily; Mayo, Rebeca; Martínez-Arranz, Ibon; Mincholé, Itziar; Banales, Jesús M.; Arrese Jiménez, Marco Antonio; Cusi, Kenneth; Arias-Loste, María Teresa; Bruha, Radan; Romero-Gómez, Manuel; Iruzubieta, Paula; Aller, Rocío; Ampuero, Javier; Calleja, José Luis; Ibáñez-Samaniego, Luis; Aspichueta, Patricia; Marín-Duce, Antonio; Kushner, Tatyana; Ortiz, Pablo
  • No Thumbnail Available
    Item
    Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)
    (2024) Noureddin, Mazen; Truong, Emily; Mayo, Rebeca; Martinez-Arranz, Ibon; Banales, Jesus M.; Minchole, Itziar; Arrese, Marco; Cusi, Kenneth; Arias-Loste, Maria Teresa; Bruha, Radan; Romero-Gomez, Manuel; Iruzubieta, Paula; Aller, Rocio; Ampuero, Javier; Calleja, Jose Luis; Ibanez-Samaniego, Luis; Aspichueta, Patricia; Martin-Duce, Antonio; Kushner, Tatyana; Ortiz, Pablo; Harrison, Stephen A.; Anstee, Quentin M.; Crespo, Javier; Mato, Jose M.; Sanyal, Arun J.
    Background: Early identification of those with NAFLD activity score >= 4 and significant fibrosis (>= F2) or at-risk metabolic dysfunction-associated steatohepatitis (MASH) is a priority as these patients are at increased risk for disease progression and may benefit from therapies. We developed and validated a highly specific metabolomics-driven score to identify at-risk MASH.